Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis
Top Cited Papers
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 18 (1), 123-132.e3
- https://doi.org/10.1016/j.cgh.2019.04.059
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Inc
This publication has 20 references indexed in Scilit:
- Inflammatory bowel disease and risk of coronary heart diseaseTrends in Cardiovascular Medicine, 2015
- Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2014
- Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*Annals Of The Rheumatic Diseases, 2013
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative ColitisNew England Journal of Medicine, 2012
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)European Heart Journal, 2012
- Genetics of Thoracic Aortic AneurysmsCurrent Atherosclerosis Reports, 2012
- The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placeboArthritis & Rheumatism, 2009
- C-Reactive Protein and Parental History Improve Global Cardiovascular Risk PredictionCirculation, 2008
- Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in WomenJAMA, 2007
- Inflammation as a Cardiovascular Risk FactorCirculation, 2004